Loading
Life sciences · Journal article
Journal of Drug Delivery and Therapeutics · October 15, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Liposomes are versatile nanocarrier systems widely investigated for pharmaceutical drug delivery because of their biocompatibility, biodegradability, and ability to encapsulate both hydrophilic and lipophilic drugs. Since their discovery in the 1960s, liposomes have evolved into advanced nanomedicine platforms with applications in cancer therapy, antimicrobial treatment, gene delivery, vaccines, and personalised medicine. Advances in lipid chemistry, nanotechnology, and pharmaceutical engineering have enabled the development of long-circulating, targeted, stimuli-responsive, and multifunctional liposomal formulations. Several liposome-based products have received regulatory approval, demonstrating their clinical and translational potential. However, challenges related to formulation stability, encapsulation efficiency, large-scale manufacturing, storage, and regulatory requirements remain. Emerging approaches, including microfluidics, artificial intelligence-assisted formulation development, precision nanomedicine, and personalised drug delivery, are expected to address these limitations. This review discusses the historical development, structural characteristics, classification, preparation methods, therapeutic applications, clinical status, and future perspectives of liposomal drug delivery systems, with particular emphasis on recent innovations driving the development of next-generation liposomal therapeutics. Keywords: Liposome, Nanomedicine,Drug Delivery System, Phospholipid Vesicles, Targeted Drug Delivery, Nanotechnology, Lipid Nanocarriers, Controlled Drug Release.